Researchers at the University of Colorado Anschutz Medical Campus have discovered a combination of drugs that may offer a better prognosis for children diagnosed with MYC-amplified Medulloblastoma, an often deadly form of brain cancer. The research was carried out in collaboration with the German Cancer Consortium (DKTK) University Hospital Dusseldorf. An oncogene called MYC is […]